Skip to main content

Table 1 Practice setting, demographic characteristics, comorbidities, and referral by provision of BZD

From: An observational study of the factors associated with frequency of outpatient benzodiazepine prescribing to patients receiving chronic opioid analgesic therapy in primary care at a major academic center

 

BZD prescription provideda

Characteristic

No

(n = 309)

Yes

(n = 148)

Total

(N = 457)

P value

Practice setting

 Service name

   

.80b

  Community Internal Medicine

150 (68.2)

70 (31.8)

220 (48.1)

 

  Family Medicine

159 (67.1)

78 (32.9)

237 (51.9)

 

 Site

   

.09b

  Arizona

203 (70.5)

85 (29.5)

288 (63.0)

 

  Florida

106 (62.7)

63 (37.3)

169 (37.0)

 

 Sex of provider

   

.86b

  Female

179 (67.3)

87 (32.7)

266 (58.2)

 

  Male

130 (68.1)

61 (31.9)

191 (41.8)

 

Demographic characteristics of patients

 Age, median (IQR), y

70 (61–79)

66 (59–75)

69 (61–77)

.02c

 Sex

   

.046b

  Female

170 (63.9)

96 (36.1)

266 (58.2)

 

  Male

139 (72.8)

52 (27.2)

191 (41.8)

 

Comorbidity

    

  Alcohol use disorder

189 (69.0)

85 (31.0)

274 (60.0)

.45b

  Depression

120 (59.7)

81 (40.3)

201 (44.0)

< .001b

  Anxiety

100 (43.1)

132 (56.9)

232 (50.8)

< .001b

  Documented fall or fall risk

99 (67.8)

47 (32.2)

146 (31.9)

.95b

  COPD

29 (67.4)

14 (32.6)

43 (9.4)

.98b

 Psychiatry or psychology referral or mental health provider established on record

   

< .001b

  No

273 (88.3)

112 (75.7)

385 (84.2)

 

  Yes

36 (11.7)

36 (24.3)

72 (15.8)

 
  1. Abbreviations: BZD, benzodiazepine; COPD, chronic obstructive pulmonary disease
  2. a Values are presented as number (percentage) unless specified otherwise
  3. b χ2 test
  4. c Kruskal-Wallis test